Provided by Tiger Fintech (Singapore) Pte. Ltd.

LifeStance Health Group, Inc.

5.85
+0.12002.09%
Post-market: 5.970.1200+2.05%17:52 EDT
Volume:2.20M
Turnover:12.71M
Market Cap:2.27B
PE:-62.52
High:5.90
Open:5.79
Low:5.61
Close:5.73
Loading ...

Stock Track | LifeStance Health Plummets 7.63% Despite Q1 Beat as Q2 Guidance Disappoints

Stock Track
·
07 May

Lifestance Health Shares Reverse Premarket Gains; Last Down 14% After Q1 Results

THOMSON REUTERS
·
07 May

Stock Track | LifeStance Health Soars 9.16% Pre-market on Strong Q1 Results and First-Ever Positive Net Income

Stock Track
·
07 May

Stock Track | LifeStance Health Soars 9.16% Pre-market on Strong Q1 Results and Positive Net Income

Stock Track
·
07 May

Lifestance Health Group's Q1 Earnings, Revenue Rise; Reiterates 2025 Revenue Guidance

MT Newswires Live
·
07 May

LifeStance reports Q1 EPS 0c vs. (6c) last year

TIPRANKS
·
07 May

LifeStance Health Gr Q1 Sales $332.97M Beat $332.90M Estimate

Benzinga
·
07 May

Earnings Flash (LFST) Lifestance Health Group Breaks Even in Q1, vs. FactSet Est of $0.04 Loss

MT Newswires Live
·
07 May

BRIEF-Lifestance Health Q1 Revenue USD 333 Million Vs. IBES Estimate USD 332.9 Million

Reuters
·
07 May

Lifestance Reports First Quarter 2025 Results

THOMSON REUTERS
·
07 May

Lifestance Health Group Inc: for FY 2025, Reiterating Expectations for REV of $1.40 Bln to $1.44 Bln

THOMSON REUTERS
·
07 May

Lifestance Health Group Inc Q2 REV View $352.8 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
07 May

Lifestance Health Outlook Q2 Adjusted Ebitda USD 28-34 Million

THOMSON REUTERS
·
07 May

Lifestance Health Group Inc Outlook Q2 Total Revenue of $332 Mln to $352 Mln

THOMSON REUTERS
·
07 May

Lifestance Health Group Inc FY2025 REV View $1.42 Bln -- Lseg Ibes Data

THOMSON REUTERS
·
07 May

Wall Street Analysts Believe LifeStance Health (LFST) Could Rally 28.68%: Here's is How to Trade

Zacks
·
05 May

LifeStance Health Group (LFST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks
·
30 Apr

3 of Wall Street’s Favorite Stocks with Questionable Fundamentals

StockStory
·
29 Apr